High efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Muheza and Kigoma Districts, Tanzania.

Malaria Journal
Celine I MandaraDeus S Ishengoma

Abstract

Artemether-lumefantrine (AL) is the recommended first-line artemisinin-based combination therapy (ACT) for the treatment of uncomplicated falciparum malaria in most of the malaria-endemic countries, including Tanzania. Recently, dihydroartemisinin-piperaquine (DP) has been recommended as the alternative anti-malarial to ensure effective case management in Tanzania. This study assessed the parasite clearance rate and efficacy of AL and DP among patients aged 6 months to 10 years with uncomplicated falciparum malaria in two sites with different malaria transmission intensity. This was an open-label, randomized trial that was conducted at two sites of Muheza Designated District Hospital and Ujiji Health Centre in Tanga and Kigoma regions, respectively. Patients meeting inclusion criteria were enrolled, treated with either AL or DP and followed up for 28 (extended to 42) and 42 (63) days for AL and DP, respectively. Parasite clearance time was monitored in the first 72 h post treatment and the clearance rate constant and half-life were calculated using an established parasite clearance estimator. The primary outcome was parasitological cure on days 28 and 42 for AL and DP, respectively, while secondary outcome was extended parasito...Continue Reading

References

Nov 13, 2001·Tropical Medicine & International Health : TM & IH·UNKNOWN East African Network for Monitoring Antimalarial Treatment (EANMAT)
Oct 1, 2003·Tropical Medicine & International Health : TM & IH·UNKNOWN East African Network for Monitoring Antimalarial Treatment (EANMAT)
Nov 9, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Issaka ZongoJean Bosco Ouédraogo
Jul 16, 2008·International Journal for Parasitology·Artemis KoukounariSimon Brooker
Dec 6, 2008·Malaria Journal·Kasia StepniewskaNicholas J White
Jan 21, 2010·The Journal of Infectious Diseases·Kasia StepniewskaNicholas J White
Jul 6, 2012·The American Journal of Tropical Medicine and Hygiene·Amelia W MaigaAbdoulaye A Djimde
Jul 31, 2014·The New England Journal of Medicine·Elizabeth A AshleyUNKNOWN Tracking Resistance to Artemisinin Collaboration (TRAC)
Jun 23, 2016·The New England Journal of Medicine·Didier MénardUNKNOWN KARMA Consortium

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
genotyping

Software Mentioned

Excel
Access
STATA

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.